These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35197403)

  • 1. [Questionnaire Survey on Adoption and Prescription of Biosimilars (Antibody and Its-related Products) by Medical Doctors in Japan].
    Aoki Y; Sai K; Katsuta Y; Suzuki M; Suzuki Y; Ishii-Watabe A; Saito Y
    Yakugaku Zasshi; 2022 May; 142(5):547-560. PubMed ID: 35197403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the Biosimilar Paradox of Oncologists' Perceptions and Hesitations in South Korea: A Web-Based Survey Study.
    Shin G; Kim BS; Kim DY; Bae S
    BioDrugs; 2024 Mar; 38(2):301-311. PubMed ID: 38212516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
    van Overbeeke E; De Beleyr B; de Hoon J; Westhovens R; Huys I
    BioDrugs; 2017 Oct; 31(5):447-459. PubMed ID: 28929342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans.
    Lepelaars LRA; Renda F; Pani L; Pimpinella G; Leufkens HGM; Trifirò G; Tafuri G; Mantel-Teeuwisse AK; Trotta F
    Br J Clin Pharmacol; 2018 Apr; 84(4):738-763. PubMed ID: 29164665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians.
    Yang J; Blinzler K; Lankin J; Vijayakumar S; Maculaitis MC; Shelbaya A
    BioDrugs; 2022 Jan; 36(1):71-83. PubMed ID: 34822141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch.
    Gasteiger C; Lobo M; Dalbeth N; Petrie KJ
    Rheumatol Int; 2021 Jan; 41(1):163-171. PubMed ID: 32300866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biosimilar road in inflammatory bowel disease: the right way?
    Fiorino G; Danese S
    Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):465-71. PubMed ID: 24913385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review.
    Moots RJ; Curiale C; Petersel D; Rolland C; Jones H; Mysler E
    BioDrugs; 2018 Jun; 32(3):193-199. PubMed ID: 29790131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction.
    Ingrasciotta Y; Cutroneo PM; Marcianò I; Giezen T; Atzeni F; Trifirò G
    Drug Saf; 2018 Nov; 41(11):1013-1022. PubMed ID: 29796832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosimilars for inflammatory bowel disease: how can healthcare professionals help address patients' concerns?
    Gecse KB; Cumming F; D'Haens G
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):143-155. PubMed ID: 30791783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars.
    Alsamil AM; Giezen TJ; Egberts TC; Doevendans E; Leufkens HG; Gardarsdottir H
    Eur J Pharm Sci; 2022 Aug; 175():106227. PubMed ID: 35636657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab.
    Giuliani J; Bonetti A
    Anticancer Res; 2019 Jul; 39(7):3971-3973. PubMed ID: 31262930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.
    Belleudi V; Trotta F; Addis A; Ingrasciotta Y; Ientile V; Tari M; Gini R; Pastorello M; Scondotto S; Cananzi P; Traversa G; Davoli M; Trifirò G;
    Drug Saf; 2019 Dec; 42(12):1437-1447. PubMed ID: 31228010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global landscape on interchangeability of biosimilars.
    Rathore AS; Stevenson JG; Chhabra H; Maharana C
    Expert Opin Biol Ther; 2022 Feb; 22(2):133-148. PubMed ID: 33567923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception of hematologists and oncologists about the biosimilars: A prospective Tunisian study based on a survey.
    Hadoussa S; Bouhlel M; Soussi MA; Drira C; Hadoussa M; Khrouf MR
    J Oncol Pharm Pract; 2020 Jan; 26(1):124-132. PubMed ID: 31106664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical specialists' attitudes to prescribing biosimilars.
    Hemmington A; Dalbeth N; Jarrett P; Fraser AG; Broom R; Browett P; Petrie KJ
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):570-577. PubMed ID: 28233367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Regulatory Concerns of Biosimilars: A Review of Literature.
    Halimi V; Daci A; Ancevska Netkovska K; Suturkova L; Babar ZU; Grozdanova A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32796549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
    Braun J; Kay J
    Expert Opin Drug Saf; 2017 Mar; 16(3):289-302. PubMed ID: 28068848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosimilars: implications for rheumatoid arthritis therapy.
    Cohen S; Kay J
    Curr Opin Rheumatol; 2017 May; 29(3):260-268. PubMed ID: 28306596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Physicians' Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated with Their Prescribing.
    Karateev D; Belokoneva N
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30754705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.